Moreover, several reports point toward involvement of gelsolin in various human cancers, due to the observation that GSN expression was downregulated in numerous types of cancers, e.g., breast, bladder, colon, gastric, kidney, lung, oral, ovarian, pancreatic, and prostate cancer (Li et al. 2012). Here, GSN is linked to prostate carcinoma.